Gossamer Bio

General Information

We are a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Our goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases. To accomplish this goal, we have assembled a deeply experienced and highly skilled group of industry veterans, scientists, clinicians and key opinion leaders from leading biotechnology and pharmaceutical companies, as well as leading academic centers from around the world.

Employees: 105
Founded: 2015
Contact Information
Address 3013 Science Park Road, Suite 200, San Diego, CA 92121, US
Phone Number (858) 684-1300
Web Address http://www.gossamerbio.com
View Prospectus: Gossamer Bio
Financial Information
Market Cap $1012.4mil
Revenues $0 mil (last 12 months)
Net Income $-114.6 mil (last 12 months)
IPO Profile
Symbol GOSS
Exchange NASDAQ
Shares (millions): 17.3
Price range $16.00 - $16.00
Est. $ Volume $276.0 mil
Manager / Joint Managers BofA Merrill Lynch/ Leerink Partners/ Barclays/ Evercore ISI
CO-Managers -
Expected To Trade: 2/8/2019
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change